Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Eldor

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Food Chemistry|May 28, 2026
sweelin®, a novel sweet protein, does not affect blood glucose and insulin levels - a double-blind, crossover, randomized studyYael Lifshitz, Rotem Saban, Shira Paz, et al.
Diabetes Care|July 17, 2025
Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration RegimenRoy Eldor, Noa Avraham, Orit Rosenberg, et al.
Diabetes Care|December 3, 2025
Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611Roy Eldor, Noa Avraham, Orit Rosenberg, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2021
The Interrelation Between Chronic Headache, Cognitive Scores, and MRI Markers Among Stroke SurvivorsJeremy Molad, Hen Hallevi, Amos D Korczyn, et al.
Diabetes Research and Clinical Practice|June 7, 2021
Effect of a primary-care-team focused diabetes educational program project on diabetes care quality indicators in a large health maintenance organizationRoy Eldor, Eugene Merzon, Miriam Shpigelman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 13, 2024
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and IsraelAdam G Tabak, Peter Kempler, Cristian Guja, et al.
Obesity Facts|October 4, 2022
The Effects of Metabolism Tracker Device (Lumen) Usage on Metabolic Control in Adults with Prediabetes: Pilot Clinical TrialAssaf Buch, Shlomo Yeshurun, Tomer Cramer, et al.
Diabetes|December 20, 2013
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individualsGiuseppe Daniele, Roy Eldor, Aurora Merovci, et al.
Journal of Clinical Medicine|April 30, 2021
Comparison of Equations Estimating Resting Metabolic Rate in Older Adults with Type 2 DiabetesAssaf Buch, Jonathan Diener, Naftali Stern, et al.
Cardiovascular Diabetology|August 26, 2023
Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adultsHadas Ben-Assayag, Rafael Y Brzezinski, Shlomo Berliner, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Food Chemistry|May 28, 2026
sweelin®, a novel sweet protein, does not affect blood glucose and insulin levels - a double-blind, crossover, randomized studyYael Lifshitz, Rotem Saban, Shira Paz, et al.
Diabetes Care|July 17, 2025
Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration RegimenRoy Eldor, Noa Avraham, Orit Rosenberg, et al.
Diabetes Care|December 3, 2025
Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611Roy Eldor, Noa Avraham, Orit Rosenberg, et al.
Journal of Alzheimer'S Disease : JAD|May 10, 2021
The Interrelation Between Chronic Headache, Cognitive Scores, and MRI Markers Among Stroke SurvivorsJeremy Molad, Hen Hallevi, Amos D Korczyn, et al.
Diabetes Research and Clinical Practice|June 7, 2021
Effect of a primary-care-team focused diabetes educational program project on diabetes care quality indicators in a large health maintenance organizationRoy Eldor, Eugene Merzon, Miriam Shpigelman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 13, 2024
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and IsraelAdam G Tabak, Peter Kempler, Cristian Guja, et al.
Obesity Facts|October 4, 2022
The Effects of Metabolism Tracker Device (Lumen) Usage on Metabolic Control in Adults with Prediabetes: Pilot Clinical TrialAssaf Buch, Shlomo Yeshurun, Tomer Cramer, et al.
Diabetes|December 20, 2013
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individualsGiuseppe Daniele, Roy Eldor, Aurora Merovci, et al.
Journal of Clinical Medicine|April 30, 2021
Comparison of Equations Estimating Resting Metabolic Rate in Older Adults with Type 2 DiabetesAssaf Buch, Jonathan Diener, Naftali Stern, et al.
Cardiovascular Diabetology|August 26, 2023
Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adultsHadas Ben-Assayag, Rafael Y Brzezinski, Shlomo Berliner, et al.
Pageof 7